Latest Insider Transactions at Savara Inc (SVRA)
This section provides a real-time view of insider transactions for Savara Inc (SVRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Savara Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Savara Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Joseph S Mc Cracken |
BUY
Open market or private purchase
|
Direct |
20,000
+8.66%
|
$40,000
$2.95 P/Share
|
|
Nov 18
2024
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
100,000
+4.13%
|
$200,000
$2.88 P/Share
|
|
Nov 10
2024
|
Raymond Dennis Pratt Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,950
-16.11%
|
$149,850
$3.97 P/Share
|
|
Oct 21
2024
|
Anne Erickson Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-0.11%
|
$1,143
$3.57 P/Share
|
|
Sep 25
2024
|
Braden C. Parker Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Jul 21
2024
|
Anne Erickson Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-0.11%
|
$1,524
$4.47 P/Share
|
|
Apr 21
2024
|
Anne Erickson Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-0.11%
|
$1,524
$4.81 P/Share
|
|
Dec 28
2023
|
David L Lowrance CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-2.84%
|
$40,000
$4.71 P/Share
|
|
Dec 28
2023
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
19,000
-1.46%
|
-
|
|
Dec 28
2023
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
84,000
-6.06%
|
$336,000
$4.71 P/Share
|
|
Dec 28
2023
|
Nevan C Elam Director |
SELL
Open market or private sale
|
Direct |
93,843
-80.66%
|
$375,372
$4.71 P/Share
|
|
Dec 28
2023
|
Nevan C Elam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
53,758
+13.94%
|
$53,758
$1.21 P/Share
|
|
Dec 15
2023
|
David L Lowrance CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
20,000
-5.37%
|
-
|
|
Dec 14
2023
|
Raymond Dennis Pratt Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+32.61%
|
-
|
|
Dec 14
2023
|
Ricky Sun |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
|
Dec 14
2023
|
David L Lowrance CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+30.06%
|
-
|
|
Dec 14
2023
|
David L Lowrance CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
30,438
-12.54%
|
$121,752
$4.45 P/Share
|
|
Dec 14
2023
|
Robert Matthew Lutz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+34.78%
|
-
|
|
Dec 14
2023
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+24.5%
|
-
|
|
Dec 14
2023
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
109,680
-10.48%
|
$438,720
$4.45 P/Share
|
|
Dec 14
2023
|
An Van Es Johansson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
|
Dec 14
2023
|
David A Ramsay |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+1.0%
|
-
|
|
Dec 14
2023
|
Nevan C Elam Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+26.44%
|
-
|
|
Dec 14
2023
|
Richard J Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+38.97%
|
-
|
|
Dec 14
2023
|
Joseph S Mc Cracken |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+10.55%
|
-
|
|
Dec 11
2023
|
Richard J Hawkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,841
+45.97%
|
$0
$0.82 P/Share
|
|
Dec 11
2023
|
Nevan C Elam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,841
+21.29%
|
$0
$0.82 P/Share
|
|
Jul 17
2023
|
Edward T Mathers > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Scott D Sandell > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Paul Edward Walker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Rick Yang > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Forest Baskett > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Ali Behbahani > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Carmen Chang > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Anthony A. Florence Jr. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Mohamad Makhzoumi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jul 17
2023
|
Growth Equity Opportunities 17, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
333,333
+1.34%
|
$999,999
$3.0 P/Share
|
|
Jun 26
2023
|
Raymond Dennis Pratt Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,500
+3.9%
|
$13,000
$2.93 P/Share
|
|
May 26
2023
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
37,124
+1.66%
|
$74,248
$2.63 P/Share
|
|
May 25
2023
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
12,876
+0.59%
|
$25,752
$2.57 P/Share
|
|
May 24
2023
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
50,000
+2.27%
|
$100,000
$2.56 P/Share
|
|
Feb 24
2023
|
Robert Matthew Lutz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
|
Dec 30
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
29,000
+1.36%
|
$29,000
$1.55 P/Share
|
|
Dec 29
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
7,000
+0.34%
|
$7,000
$1.54 P/Share
|
|
Dec 28
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
3,293
+0.16%
|
$3,293
$1.5 P/Share
|
|
Dec 23
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
15,707
+0.76%
|
$15,707
$1.44 P/Share
|
|
Dec 22
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
41,414
+1.98%
|
$41,414
$1.48 P/Share
|
|
Dec 22
2022
|
Raymond Dennis Pratt Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,500
+2.23%
|
$3,500
$1.54 P/Share
|
|
Dec 20
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
17,416
+0.43%
|
$17,416
$1.49 P/Share
|
|
Dec 19
2022
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
40,719
+2.01%
|
$40,719
$1.49 P/Share
|